Join Roger Longman, co-founder of Real Endpoints and recognized expert in biopharmaceutical strategy for a look at the US payer market. Longman shares his unique insights and expertise about the economics and dynamics of medical reimbursement, and the rising importance of payers and payers’ agents to the biopharma industry.
You’ll hear about the reasons why payers are nervous about the number of specialty drugs coming on the market, how PBMs manage costs for sponsors and payers, why drugs impact different medical reimbursement plans differently, how drug rebates figure in the mix, and how payers can sometimes cut the use of highly innovative products with restrictive coverage policies. The session also includes an important to-do list for biopharma to survive and thrive with changing payer dynamics.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: